AI Article Synopsis
- Gastric cancer (GC) is the fifth most common cancer globally, and the study aims to explore its linkage to a newly discovered cell death pathway called cuproptosis.
- The research will focus on cuproptosis in relation to immunotherapy and biomarkers in GC, aiming to clarify its role in cancer diagnosis and prognosis.
- Ultimately, the study intends to suggest future research directions and strategies to better understand cuproptosis in the context of gastric cancer.
Article Abstract
Gastric cancer (GC) is the fifth most prevalent type of cancer in the whole world. Cuproptosis is discovered as a programmed cell death pathway and connected to cells' growth and death, as well as tumorigenesis. The relationship between cuproptosis and GC is still elusive. Two aspects of this study will elaborate the relationship between cuproptosis and immunotherapy as well as biomarkers in GC. Notably, the herein review is intended to highlight what has been accomplished regarding the cuproptosis for the diagnosis, immunotherapy, and prognosis in GC. The aim of this study is to offer a potential directions and the strategies for future research regarding cuproptosis inside the GC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.biopha.2024.117100 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!